TIMM23 and pulmonary fibrosis: We found that reduction of TIM23–NOX4 interaction abrogates mitochondrial ROS and metabolic reprogramming, suggesting that TIM23–NOX4 interaction may become an important therapeutic target for the treatment of lung fibrosis.